Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 7.37
-1.47 %
$ 399 M
Market Cap
-1.88
P/E
EBS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities EBS - Emergent BioSolutions Inc.
-536 M
LAST VALUE
-94.92%
2 YEAR CAGR
-10.92%
5 YEAR CAGR
-51.38%
10 YEAR CAGR